Fundraising FoxBiotech Startups
11,051 companies tagged Biotech, with their investors and founders.
Heligenics is a genomics and cell biology company that develops assays and platforms for drug screening and genetic analysis. The company serves pharmaceutical and biotech organizations conducting research in functional genomics and cellular engineering.
0 investors
A digital asset treasury company that acquires and holds Solana tokens to maximize SOL per share through treasury management and staking activities, while maintaining a secondary focus on neurotechnology for neurological wellness.
0 investors
Helix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
0 investors
Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.
0 investors
Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Hepanova is a clinical-stage biotech developing first-in-class oral small-molecule therapeutics for chronic liver diseases and inflammatory conditions, including MASH, liver fibrosis, and IBD. Its lead candidate, HPN-01, is an oral dual IKKα/IKKβ inhibitor that has completed a U.S. Phase 1 trial.
0 investors
Hepion Pharma is a pharmaceutical company with a therapeutic focus on hepatocellular carcinoma (liver cancer). This page is an investor presentations section with no substantive content available.
0 investors
0 investors
0 investors
Hexamer Therapeutics develops a modular, room-temperature, peptide-based vaccine platform for therapeutic cancer and infectious disease vaccines, aiming to move quickly from disease target to active vaccine. It also licenses the platform to companies developing vaccines for animals such as swine, cattle, sheep, horses and companion animals.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors